AzTrials
AzTrials

Research institution

Universitaire Ziekenhuizen KU Leuven Clinical Trials

Studies where Universitaire Ziekenhuizen KU Leuven is the lead sponsor: what is enrolling now, by phase, condition and country.

958 registered studies

In numbers

Open to volunteers
174
Active
199
With results posted
30
All registered
958

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 174
  • Atrial Fibrillation (AF), Coronary Artery Disease

    Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation

    • Recruiting
    • Age: 18 years and older
    • Phase 4

    The goal of this clinical trial is to learn whether the antiarrhythmic drug flecainide can be used as safely as standard rhythm-control drugs in people with atrial fibrillation (AF) and stable coronary artery disease (CAD).

    Trial name
    ReCAST AF (NCT07405671)
    Testing
    flecainide, Sotalol or Amiodarone
    Where
    14 sites in Belgium
    Volunteers
    988 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? ReCAST AF
  • ASD, Scoliosis Idiopathic Adolescent

    Quality of Life, Psychosocial Burden, and Structural-functional Status in Adults With Spinal Deformity.

    • Recruiting
    • Age: 18 years and older
    • Surgery or procedure

    This study examines which factors influence quality of life in adults with a spinal deformity. It looks at imaging findings together with pain, daily functioning, psychosocial factors, and frailty to support more person-centred…

    Conditions
    ASD, Scoliosis Idiopathic Adolescent, Scoliosis Idiopathic Adolescent Treatment
    Trial name
    ASD-QoL (NCT07749534)
    Testing
    first corrective surgery, Reoperation
    Where
    Belgium
    Volunteers
    320 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? ASD-QoL
  • Endometriosis, Deep Infiltrating Endometriosis

    Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis

    • Recruiting
    • Age: 18 to 64 years
    • Pill or oral medicine
    • Injection or infusion

    The goal of this clinical trial is to learn whether [18F]AlF-FAPI-74 PET/CT can help detect endometriosis in adult women who are already scheduled for laparoscopy due to suspicion of deep infiltrating endometriosis or superficial…

    Conditions
    Endometriosis, Deep Infiltrating Endometriosis, Women, Superficial Peritoneal Endometriosis
    Trial name
    EM-FAPI (NCT07876648)
    Testing
    [18F]AlF-FAPI-74 PET/CT
    Where
    Belgium
    Volunteers
    64 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? EM-FAPI
  • Bradyarrhythmias, AV Block Complete

    Belgo-Luxembourg Leadless PM Registry

    • Not yet recruiting
    • Age: 18 years and older
    • Surgery or procedure

    This is a single-arm, multicenter clinical study evaluating the long-term effectiveness and safety profile of the CE-marked and commercially available Aveir leadless pacemaker systems manufactured by Abbott.

    Conditions
    Bradyarrhythmias, AV Block Complete, AV Block-2Nd Degree-Type 1, Pacemaker
    Trial name
    BELLA (NCT07879716)
    Testing
    CT scan heart, 24 hour ambulatory ECG monitoring
    Where
    9 sites in Belgium, Luxembourg
    Volunteers
    190 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? BELLA
  • Obesity & Overweight

    A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating Spectrum

    • Recruiting
    • Age: 18 to 65 years
    • Phase 4
    • Injection or infusion

    The goal of this clinical trial is to investigate how GLP-1 receptor analogs, such as semaglutide (Wegovy®), influence processes that determine eating behavior, binge eating, and weight regulation via the gut-brain axis.

    Trial name
    SEM-BEAT (NCT07870538)
    Testing
    Semaglutide 3,2 mg/ml
    Where
    Belgium
    Volunteers
    96 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? SEM-BEAT
  • General Anaesthesia During Pregnancy

    Intelligence and Neurodevelopmental Disorders After Prenatal Exposure to General Anaesthesia

    • Enrolling by invitation
    • Age: 6 to 27 years
    • Observational study
    • Injection or infusion

    Every year in the European Union, thousands of babies are exposed to anaesthesia before they are born because their mothers need surgery during pregnancy.

    Trial name
    PAE-IQ (NCT06633406)
    Testing
    Age-appropriate Wechsler Intelligence Test, Disruptive Behavior Disorders Rating Scale, Social Responsiveness Scale
    Where
    3 sites in Belgium
    Volunteers
    192 people, healthy volunteers welcome
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? PAE-IQ
  • Hepatocellular Carcinoma (HCC)

    STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma

    • Recruiting
    • Age: 18 years and older
    • Observational study

    STRATHEP develops and validates a multimodal AI model to predict treatment response in advanced hepatocellular carcinoma. By integrating digital pathology and MRI radiomics, the project identifies patients likely to benefit from…

    Trial name
    STRATHEP (NCT07863258)
    Where
    5 sites in Belgium
    Volunteers
    280 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? STRATHEP
  • Oral Cancer, Head and Neck Cancer

    Rehabilitation Through Individualized Support and Exercise

    • Not yet recruiting
    • Age: 18 years and older
    • Pill or oral medicine

    Oral cancer, the most prevalent form of head and neck malignancy, represents a major global health burden, with over 370,000 new cases annually according to the World Health Organization.

    Trial name
    RISE (NCT07857096)
    Testing
    Tailored physiotherapy program for early mobilization after oral cancer surgery
    Where
    Belgium
    Volunteers
    39 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? RISE
  • Multiple Myeloma, Hematologic Diseases

    Study on the Clinical Efficacy of Teclistamab and Talquetamab

    • Recruiting
    • Age: 18 years and older
    • Observational study

    The aim of this study is to assess the clinical efficacy of the anti-BCMA/CD3 bispecific antibody teclistamab and anti-GPRC5D/CD3 bispecific antibody talquetamab in a prospective, real-life setting in Belgium.

    Trial name
    BIONIC (NCT06477783)
    Testing
    Teclistamab
    Where
    17 sites in Belgium
    Volunteers
    100 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? BIONIC
  • Amyloidosis, AL Amyloidosis

    BE.Amycon Biobank & Data Registry UZ Leuven

    • Recruiting
    • Age: 18 years and older
    • Observational study

    The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database…

    Conditions
    Amyloidosis, AL Amyloidosis, Amyloidosis Cardiac
    Trial name
    NCT07172243
    Where
    2 sites in Belgium
    Volunteers
    505 people, healthy volunteers welcome
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? NCT07172243

Completed, with results posted

All –
  • ADHD, Sleep

    Sleep IntervEntion as Symptom Treatment for ADHD

    • Completed
    • Age: 13 to 17 years
    • Lifestyle or therapy programme
    • Results posted

    Up to 72% of adolescents with ADHD portray sleep problems. The most common sleep difficulties in adolescents with ADHD are initial insomnia, nocturnal awakenings, non-restorative or restless sleep.

    Conditions
    ADHD, Sleep, Adolescents, CBT
    Trial name
    SIESTA (NCT04723719)
    Testing
    SIESTA, Treatment as usual for ADHD
    Where
    Belgium
    Volunteers
    92 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? SIESTA
  • Aortic Stenosis, Coronary Artery Disease

    COronary and MICrocirculatory Measurements in Patients With Aortic Valve Stenosis.

    • Completed
    • Age: 18 years and older
    • Observational study
    • Results posted

    Although concomitant coronary artery disease (CAD) is frequent in patients with severe aortic stenosis (AS), hemodynamic assessment of CAD severity in patients undergoing valve replacement for severe AS is challenging.

    Trial name
    COMIC-AS (NCT04420325)
    Where
    3 sites in Belgium
    Volunteers
    116 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? COMIC-AS
  • Spastic Cerebral Palsy

    Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy

    • Completed
    • Age: 4 to 11 years
    • Injection or infusion
    • Results posted

    This study investigates the effect of integrated Botulinum Neurotoxin A (BoNT) treatment on morphologic muscle and tendon properties, spasticity, joint stiffness, joint range of motion, muscle strength, gait and gross motor…

    Trial name
    NCT05126693
    Testing
    Botulinum Toxin treatment combined with a post-BoNT intensive physical therapy period guided by individualized treatment goals.
    Where
    Belgium
    Volunteers
    61 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? NCT05126693
  • Cerebral Palsy, Spastic

    Progressive Supervised Home-based Strength Training in Children With Spastic Cerebral Palsy

    • Completed
    • Age: 5 to 11 years
    • Lifestyle or therapy programme
    • Results posted

    A randomized controlled trail will be carried out to investigate the effect of a 12-week supervised home-based progressive strength intervention in children with spastic cerebral palsy aged 5-11 years.

    Trial name
    NCT03863197
    Testing
    Progressive strength training
    Where
    2 sites in Belgium
    Volunteers
    49 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
  • Ovarian Cancer, Fallopian Tube Cancer

    European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer

    • Completed
    • Age: 18 years and older
    • Phase 2
    • Pill or oral medicine
    • Injection or infusion
    • Results posted

    This study will be performed in women with platinum-sensitive, high-grade serous, high-grade endometrioid, undifferentiated epithelial ovarian cancer, carcinosarcoma, fallopian tube or primary peritoneal cancer (proven by central…

    Conditions
    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    Trial name
    EUDARIO (NCT03783949)
    Testing
    Ganetespib, Niraparib, Carboplatin
    Where
    13 sites in Austria, Belgium and 3 more
    Volunteers
    122 people
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    Can I take part? EUDARIO

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in